Hologic (NASDAQ: HOLX) reported Q2 EPS of $2.07, $0.47 better than the analyst estimate of $1.60. Revenue for the quarter came in at $1.44 billion versus the consensus estimate of $1.29 billion.

GUIDANCE:

Hologic sees FY2022 EPS of $5.45-$5.65, versus the consensus of $5.15. Hologic sees FY2022 revenue of $4.6-4.7 billion, versus the consensus of $4.53 billion.

For earnings history and earnings-related data on Hologic (HOLX) click here.